US2014030309A1PendingUtilityA1
Disrupted cartilage products
Est. expiryJul 11, 2032(~6 yrs left)· nominal 20-yr term from priority
A61L 27/3612A61L 2430/06A61L 27/3683A61K 38/014A61L 27/3691A61L 27/54A61L 27/24A61L 27/3608A61L 27/56A61L 27/3817A61L 27/3687A61K 35/32A61L 2300/64A61L 27/3654A61L 27/3852A61L 2300/414A61L 27/50
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides disrupted cartilage products, methods of manufacturing disrupted cartilage products, and methods of treating a subject comprising administering a cartilage product. The cartilage products are manufactured by a method comprising disrupting a collagen matrix, e.g. to produce a flexible cartilage product. Optionally, the cartilage products comprise viable chondrocytes, bioactive factors such as chondrogenic factors, and a collagen type II matrix. Optionally, the cartilage products are non-immunogenic.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A cartilage product comprising a disrupted collagen matrix.
2 . The cartilage product of claim 1 , wherein the collagen matrix comprises enzymatic disruptions.
3 . The cartilage product of claim 2 , wherein the collagen matrix is collagenase-digested, optionally wherein the collagen matrix is collagenase II-digested.
4 . The cartilage product of claim 1 , wherein the collagen matrix comprises mechanical disruptions.
5 . The cartilage product of claim 4 , wherein the mechanical disruptions are partial mechanical disruptions, wherein the collagen matrix is substantially intact.
6 . The cartilage product of claim 5 , wherein the mechanical disruptions are selected from: spiral cut, grooves, scores, fenestrations, and pores.
7 . The cartilage product of claim 4 , wherein the mechanical disruptions are full mechanical disruptions, optionally wherein the collagen matrix minced.
8 . The cartilage product of claim 4 , wherein the mechanical disruptions are of the tissue-removal type.
9 . The cartilage product of claim 4 , wherein the mechanical disruptions are of the tissue-non-removal type.
10 . The cartilage product of claim 8 , wherein the mechanical disruptions extend through the entire thickness of the collagen matrix.
11 . The cartilage product of claim 10 , wherein the mechanical disruptions are selected from: spiral cut, scores, intersecting scores, radial scores, hoop-cut, and pores.
12 . The cartilage product of claim 8 , wherein the mechanical disruptions extend through less than the entire thickness of the collagen matrix.
13 . The cartilage product of claim 12 , wherein the mechanical disruptions are selected from: spiral cut, scores, intersecting-scores, and radial scores.
14 . The cartilage product of claim 1 , wherein the collagen matrix has a thickness of about 0.2 mm to about 2.0 mm.
15 . The cartilage product of claim 14 , wherein the collagen matrix has a thickness of about 1 mm to about 1.5 mm.
16 . The cartilage product of claim 1 , wherein the collagen matrix contains viable cells, optionally wherein the viable cells are native to the collagen matrix.
17 . The cartilage product of claim 1 , wherein the collagen matrix is decellularized.
18 . The cartilage product of claim 15 , further comprising a layer of bone, optionally wherein the layer of bone is native to the collagen matrix.
19 . The cartilage product of claim 18 , wherein the layer of bone has a surface area substantially less than that of the collagen matrix.
20 . The cartilage product of claim 19 , wherein the layer of bone is a plug, a shelled plug, or a shelled layer or bone.Join the waitlist — get patent alerts
Track US2014030309A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.